NCT06064526Completed
An Observational, Retrospective Multicentre Medical Record Review to Describe the Post-authorisation Early Clinical Experience of Dupilumab in the Treatment of Adult Severe Asthma
Real-world Experience of Dupilumab for the Treatment of Severe Asthma in the United Kingdom: a Retrospective Study
Source: ClinicalTrials.gov · Last updated 14 Nov 2024
Brief summary (registry, in English)
The purpose of this retrospective medical record review is to describe the real-world clinical effectiveness of dupilumab with patients in the United Kingdom with severe asthma.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 144 (actual)
- First submitted
- 26 Sept 2023
- Start date
- 19 Apr 2023
- Primary completion date
- 15 Oct 2024
- Lead sponsor
- Sanofi
- Diseases
- Asthma
- NCT number
- NCT06064526
What you commit to
- Study type: Observational
- Participants enrolled: 144
- From 19 Apr 2023 to the primary completion date, 15 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Participants known to have opted out of participation in research • Participants whose medical records are not available for review The above information is not intended to contain all considerations relevant to a potential participation in a clinical trial.
Who the study is looking for
- Adult participants (aged ≥18 years at index) with severe asthma, initiated with dupilumab treatment (≥1 dose) between 07/05/2019 (EU licence) and 08/12/2021 • Participants with ≥1 routine asthma clinic visit recorded within 6 months prior to or on the date of dupilumab initiation and ≥1 routine asthma clinic visit recorded between 9 and 16 months post-dupilumab initiation
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Sanofi-Aventis, France Coordinator of this site? Confirm its status | Chilly-Mazarin | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.